Shufen Cao

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Pre-radiotherapy lymphocyte count and platelet-to-lymphocyte ratio may improve survival prediction beyond clinical factors in limited stage small cell lung cancer: model development and validation”.

Pre-radiotherapy lymphocyte count and platelet-to-lymphocyte ratio may improve survival prediction beyond clinical factors in limited stage small cell lung cancer: model development and validation

Translational Lung Cancer Research(2020)10.21037/tlcr-20-666

N/A

0.442DataRank · unranked

18 citations

Linlin Wang, Shufen Cao, Siming Gao, Weili Wang, Lianne Mulvihill +5 more

Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab

Frontiers in Medicine(2020)10.3389/fmed.2020.588526

N/A

0DataRank · unranked

11 citations

Yasmin Arafah, Pingfu Fu, Shufen Cao, Alvin H. Schmaier, Lalitha Nayak +1 more

Towards the NMR solution Structure and the Dynamics of the C-terminal Region of APOL1 and its G1, G2 Variants with a Membrane Mimetic

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.16.435683

N/A

0DataRank · unranked

1 citations

Alexandar L. Hansen, Shufen Cao, John R. Sedor, Matthias Buck, Sethu M. Madhavan